A comparison of the post‐marketing safety of four selective serotonin re‐uptake inhibitors including the investigation of symptoms occurring on withdrawal
- 1 December 1996
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 42 (6) , 757-763
- https://doi.org/10.1046/j.1365-2125.1996.00498.x
Abstract
1We have addressed the question of whether there is a ‘serotonin withdrawal syndrome’ by analysis of spontaneous reports of suspected adverse drug reactions (ADRs) associated with four SSRIs. A comparison of the post-marketing safety profiles of the four SSRIs has also been made.Keywords
This publication has 0 references indexed in Scilit: